Patent · US Active

Haemophilus influenzae fusion protein and construction method and use thereof

US10716847B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

CANSINO BIOLOGICS INC. · CN

Inventors

Junqiang Li · Sunnyvale, US
Danqing Miao · Tianjin, CN
Mingming Yang · Xianyang, CN
Zhongqi Shao · Tianjin, CN
Tao Zhu · 安丰镇, CN
Xuefeng Yu · Yichang City, CN

Key dates

Filing date	Mar 29, 2018
Grant date	Jul 21, 2020
Priority date	—
Expiry date	Jun 6, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a fusion protein and a construction method thereof. The fusion method consists of: a Haemophilus influenzae protein D and a Hin47 (Htra) protein. The fusion protein can serve as a protein vehicle for a Haemophilus influenzae polysaccharide-protein conjugate vaccine, thereby increasing immunogenicity of a polysaccharide antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.